Announcements Trials
Browse Landscape

Phase

Phase 2 205Phase 1 179Phase NA 79Phase 1/2 76Phase EARLY_PHASE1 28Phase 3 25Phase 2/3 6Phase 4 4

Status

Completed 27Recruiting 14Unknown 12Withdrawn 4Terminated 4Active not recruiting 3Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 29Genitourinary 23Thoracic 20Breast 19Other hematologic neoplasm 16Lymphoid 14Dermatologic 10Gynecologic 8Classical hematology 8Head & Neck 6Myeloid 5CNS 4Tumor-Agnostic 3Sarcoma 3Other 3Plasma cell 2Endocrine 2Other solid neoplasm 1Other neoplasm 1NET 1

Conditions

Brain Neoplasms 3Recurrence 1Glioma 1Glioblastoma 1Epilepsy 1Drug Resistant Epilepsy 1

Interventions

perampanel 1Fluoresceins 1Fluorescein 1Anticonvulsants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Terminated × CNS × Clear all
NCT04650204 2023-06-22

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Mayo Clinic

Phase 4 Terminated
4 enrolled 9 charts
CNS

Drug Resistant Epilepsy, Epilepsy, Glioma

NCT02028325 2016-11-08

Fluorescein

Indiana University

Phase 4 Terminated
136 enrolled 4 charts
CNS

Brain Neoplasms

NCT01756729 2016-03-02

Post-approval Study of NovoTTF-100A in Recurrent GBM Patients

NovoCure Ltd.

Phase 4 Terminated
13 enrolled
CNS

Brain Neoplasms, Glioblastoma, Recurrence

NCT00415467 2012-08-02

Treatment of Resectable Malignant Brain Tumors

M.D. Anderson Cancer Center

Phase 4 Terminated
13 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡